Clinical

Discover results-proven tools and methodologies for your clinical development. Learn how to improve your trial design, data collection and clinical supply. In addition, get key information on how to improve your patient recruitment and retention. Pharma IQ is proud to provide an international, non-biased, central resource, for professionals working in clinical development to exchange ideas on best practice and share case studies on innovation within the area.
 

Fleeing India: What Will Make Clinical Trials Flood Back

Contributor: Ghida Harfouche
Posted: 8/11/2014

Fleeing India: What Will Make Clinical Trials Flood Back - Ghida Harfouche

India’s clinical trial industry has seen it all. In less than 10 years, the country has grown to become a leading destination for clinical trials, attracting studies from multinational pharma companies and contract research organizations. This however is no longer the case as the once skyrocket growth has now come to a brutal end. If India’s clinical trial industry is to pick up again, a major restructuring of its regulatory system will have to take place. Full Article »


Events related to this topic:

Experiences with IRT- An Interview with CTS manager Michael Pompey

Contributor: Michael Pompey
Posted: 10/22/2013


Experiences with IRT- An Interview with CTS manager Michael Pompey - Michael Pompey

Ahead of the Clinical Trial Supply Europe event, Pharma IQ presents interviews filmed live at last year's CTS event. In this interview Michael Pompey talks about the daily challenges he faces as a clinical trial supply manager at Sandoz and he discusses his experience with IRT. Full Video »


Events related to this topic:

Epigenetic Cancer Therapies and the TOPAS Trial- An Interview with Hella Kohlhof - Gerald Clarke

For Dr Hella Kohlhof, the study of epigenetics was not love at first sight, however the potential it posesses eventually won her over. Now Dr Kohlhof is Manager of Translational Pharmacology at 4SC AG and is applying epigenetic knowledge in a phase 1 first-in-man trial. She talks to us about what role epigentics plays in cancer and how new therapies are taking advantage of epigenetic mechanisms. Full Podcast »


Events related to this topic:

Adapting to Disruptive Change in the Pharmaceutical Industry

Contributor: Andrew Parsons
Posted: 4/8/2013


Adapting to Disruptive Change in the Pharmaceutical Industry - Andrew Parsons

The Pharmaceutical Industry continues to change at what feels like an exponential pace. What used to be a stable industry now faces almost continual re-shaping as the life cycle of R&D and commercialisation adapts to new players and shapers. New Pharma IQ columnist, Andrew Parsons explains. Full Column »


Events related to this topic:

Which Popular Drugs Are Going Off-Patent in 2014-2016?

Now that we’re at the edge of the cliff, do you know which blockbusters will be going off patent in the next 3 years? By popular request, Pharma IQ has put together a handy snapshot of all the top drugs facing imminent generic competition. Full Whitepaper »


Events related to this topic:



Advertise With Us

Join the Pharmas IQ Community